OA biomarkers showing promise but remain a research tool for now


Biomarkers continue to show promise in their potential to predict longer term clinical outcomes-both pain and structural progression in osteoarthritis, but they are still a way off surpassing MRI in effectiveness, says a leading rheumatologist. Professor David Hunter, Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney and the Royal ...


Already a member? Login to keep reading


OR
© 2017 the limbic